ResearchViews Home
Login
Registration
Home
Latest News
Latest Deals
Report Store
Contact Us
Sign up for our FREE Weekly
Immunology
ResearchViews Update.
Please enter your email address below
*
:
Related Industries
Pharma
Cardiovascular
Central Nervous System
Dermatology
ENT Disorders
Gastroenterology
Genito Urinary System and Sex Hormones
Hematology Disorders
Hormonal Disorders
Immunology
Infectious Disease
Male Health
Metabolic Disorders
Mouth and Dental Disorders
Musculoskeletal
Oncology
Ophthalmology
Respiratory
Women's Health
Medical
Cardiovascular Devices
Dental Devices
Diabetes Care Devices
Diagnostic Imaging
Drug Delivery Devices
Endoscopy Devices
ENT Devices
Healthcare IT
Hospital Supplies
In Vitro Diagnostics
Nephrology and Urology Devices
Neurology Devices
Ophthalmic Devices
Orthopedic Devices
Patient Monitoring
Respiratory Devices
Surgical Equipment
Wound Care Management
"
"
Click Here
Free Research Papers
Latest Immunology Reports
Latest Immunology Deals
Astellas Pharma Enters Into Co-Development Agreement With UCB For Cimzia
Published: Feb 01 2012
Raptor Pharmaceutical Files Registration Statement For Public Offering Of Securities For $100 Million
Published: Jan 27 2012
Amgen To Acquire Biotechnology Company, Micromet For $1.16 Billion
Published: Jan 26 2012
CEL-SCI Announces Private Placement Of Common Stock For $5.8 Million
Published: Jan 26 2012
Chelsea Therapeutics Files Shelf Registration Statement For Public Offering Of $100 Million
Published: Jan 26 2012
Latest Immunology News
Cytomedix Appoints David E Jorden As Executive Chairman
Date of story: Feb 03 2012
Medical Researchers From University Of Texas Health Science Center Present Positive Data On Athersys's MultiStem To Treat Stroke
Date of story: Feb 03 2012
Prometheus Laboratories Appoints Anthony Yost As Senior Vice President And Chief Commercial Officer
Date of story: Feb 03 2012
Dr. Reddy’s Reports Revenue Of $522m In Q3 Fiscal 2012
Date of story: Feb 03 2012
AstraZeneca Reports Revenue Of $8.7 Billion In Q4 2011
Date of story: Feb 02 2012
Latest Immunology Reports
Immunomodulators Market to 2017- Immunosuppressant Antibodies to Replace Antimetabolites as the Highest Value Sector by 2017
By: GBI Research, Published: Feb-2012
Angioedema - Pipeline Review, H1 2012
By: Global Markets Direct, Published: Jan-2012
Autoimmune Diseases Therapeutics Market 2017 - Launch of Gilenya and Bynlesta to Drive the Growth of MS and SLE Therapeutics Market Significantly
By: GBI Research, Published: Jan-2012
Graft Versus Host Disease (GVHD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
By: GlobalData, Published: Jan-2012
Graves Disease - Pipeline Assessment and Market Forecasts to 2019
By: GlobalData, Published: Jan-2012